REFERENCES
- Booth A.A., Khalifah R.G., Todd P., Hudson B.G. (1997) J. Biol. Chem., 272, 5430–5437.
- Bolton W.K., Daniel C., Cattran D.C. et al.. (2004) Am. J. Nephrol., 24, 32–40.
- Boyanova M., Mironova R., Niwa T., Ivanov I. (2008) Chapter 40 In: Infectious Diseases, Humana Press, NJ, USA, pp 365–373.
- Boyanova M., Tsanev R., Ivanov I. (2002) Anal. Biochem., 308, 178–181.
- Bradford M.M. (1976) Anal. Biochem., 72, 248–254.
- Cherian M. and Abraham E.C. (1993) Life Sci., 52, 1699–1707.
- Ganea E., Rixon K.C., Harding J.J. (1994) Biochim. Biophys. Acta, 1226, 286–290.
- Ganea E. and Harding J.J. (1996) Ophthalmic Res., 28(Suppl. 1), 65–68.
- Harding J.J. (1985) Adv. Protein Chem., 37, 247–334.
- Jakus V. and Rietbrock N. (2004) Physiol. Res., 53, 131–142.
- Lauren S.L., Arakawa T., Stoney K., Rohde M.F. (1993) Arch. Biochem. Biophys., 306, 350–353.
- Maillard L.C. (1912) C. R. Acad. Sci., 154, 66–68.
- Marekov L.N., Vassileva R.A., Ivanov V.P., Sarafova A.A., Zanev R.G., Ivanov I.G., Ivanova V.S. (1991) Method for producing human cysteine less gamma-interferon free of methionine at N-terminal, Eur. Patent App. No 0446582 AI.
- Mironova R., Niwa T., Hayashi H., Dimitrova R., Ivanov I. (2001) Mol. Microbiol., 39, 1061–1068.
- Mironova R., Niwa T., Dimitrova R., Boyanova M., Ivanov I. (2003) J. Biol. Chem. 278, 51068–51074.
- Mironova R., Niwa T., Handzhiyski Y., Sredovska A., Ivanov I. (2005) Mol. Microbiol., 55, 1801–1811.
- Monnier V.M., Stevens V.J., Cerami A. (1981) Prog. Food Nutr. Sci., 5, 315–327.
- Nakamura S. and Niwa T. (2005) J. Am. Soc. Nephrol., 16, 144–150.
- Niwa T., Katsuzaki T., Miyazaki S. et al.. (1997) J. Clin. Invest., 99, 1272–1280.
- Okada M. and Ayabe Y. (1995) J. Nutr. Sci. Vitaminol. (Tokyo), 41, 43–50.
- Onorato J.M., Jenkins A.J., Thorpe S.R., Baynes J.W. (2000) J. Biol. Chem., 275, 21177–21184.
- Reiser K.M. (1998) Proc. Soc. Exp. Biol. Med., 218(1), 23–37.
- Rendell M., Nierenberg J., Brannan C. et al.. (1986) J. Lab. Clin. Med., 108, 286–293.
- Shastri G.V., Thomas M., Victoria A.J., Selvakumar R., Kanagasabapathy A.S., Lakshmi T.K. (1998) Indian J. Exp. Biol., 36, 651–657.
- Singh R., Barden A., Mori T., Beilin L. (2001) Diabetologia, 44, 129–146.
- Taguchi T., Sugiura M., Hamada Y., Miwa I. (1998) Biochem. Pharmacol., 55, 1667–1671.
- Thornalley P.J. (2003) Arch. Biochem. Biophys., 419, 31–40.
- Thornalley P.J., Yurek-George A., Argirov A.K. (2000) Biochem. Pharmacol., 60, 55–65.
- Tsanev R. and Ivanov I. (2001) Immune Interferon: Properties and Clinical Applications, CRC Press, Boca Raton, FL.
- Tsekovska R., Boyanova M., Mironova R., Ivanov I. (2009) Biotech. & Biotechnol. Eq., 23(1), 1063–1967.
- Voziyan P.A., Khalifah R.G., Thibaudeau C., Yildiz A., Jacob J., Seriani S. et al.. (2003) J. Biol. Chem., 278, 46616–46624.
- Voziyan P.A., Metz T.O., Baynes J.W., Hudson B.G. (2002) J. Biol. Chem., 277, 3397–3403.
- Urios P., Grigorova-Borsos A.M., Sternberg M. (2007) Diabetes Res. Clin. Pract., 77, 337–340.